NCT00290212View on ClinicalTrials.gov

Natto Supplementation to Prevent Loss of Bone Mass in Women Immediately After Menopause

PHASE2CompletedINTERVENTIONAL
Enrollment

304

Participants

Timeline

Start Date

January 31, 2006

Study Completion Date

June 30, 2007

Conditions
Perimenopausal Bone Loss
Interventions
DRUG

Natto capsules (food suppl.) cont. 360 microg. vit K2/day

DRUG

Placebo capsules

Trial Locations (2)

N-9038

Clinical Research Center, University Hospital of North Norway, Tromsø

NO 5021

Haukeland University Hospital, Bergen

All Listed Sponsors
collaborator

University of Tromso

OTHER

collaborator

The International Osteoporosis Foundation

OTHER

collaborator

Haukeland University Hospital

OTHER

lead

University Hospital of North Norway

OTHER

NCT00290212 - Natto Supplementation to Prevent Loss of Bone Mass in Women Immediately After Menopause | Biotech Hunter | Biotech Hunter